Back to MW MARSHALL WACE, LLP

TMCITMCI
Showing 8 of 17 quarters

Position history for MWMARSHALL WACE, LLP's holdings in TREACE MED CONCEPTS INC

MARSHALL WACE, LLP holds 264,933 shares of TMCI (TREACE MED CONCEPTS INC), worth $355,010 as of 2026-Q1. This is a new position. TMCI represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$355,010

Current Shares

264,933

Total Value Change

-$2.7M

Total Shares Change

-198,106

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
New
264,933
-
$355,0100.0%$1.57
33
2025-Q4
Exited
0
-100.0%
$00.0%$2.48
0
2025-Q3
Decreased
11,758
-91.3%
$78,8960.0%$6.72
0
2025-Q2
Increased
135,877
+256.2%
$798,9560.0%$5.75
40
2025-Q1
Decreased
38,148
-57.1%
$320,0610.0%$8.45
0
2024-Q4
Decreased
88,910
-79.2%
$661,4920.0%$6.88
0
2024-Q3
Decreased
426,730
-7.8%
$2.5M0.0%$5.77
0
2024-Q2
Increased
463,039
+65.9%
$3.1M0.0%$6.65
39

Other major holders of TMCI: CIBC Bancorp USA Inc., CIBC Private Wealth Group LLC, ALLIANCEBERNSTEIN L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used